Omminea A. Abdullah Author

Research Article Subscription

Ischaemia Modified Albumin as a New Biomarker in the Early Diagnosis of Acute Coronary Syndrome

Author(s):

Mohamed A Tabl, Mohamed Mahrous, Reda B. Bastawesi, Amal Abou El Fadle and Omminea A. Abdullah

Ischaemia Modified Albumin as a New Biomarker in the Early Diagnosis of Acute Coronary Syndrome

Background: Early identification of acute coronary syndrome (ACS) is important. CK-MB and cardiac troponins show a delayed rise approximately 3 to 6 hours after the onset of pain. Ischaemia modified albumin (IMA) has been licensed through FDA for the early diagnosis of myocardial ischaemia. This study aimed to assess the role of IMA in the early diagnosis of ACS.

Methods: This study was conducted on 60 patients who were admitted in the Cardiac Care Unit (CCU) of Benha University Hospitals with acute chest pain less than 3 ... view more»

DOI: 10.4172/2324-8602.1000242

Abstract HTML PDF